Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma, new study presented at UEG Week suggests
VIENNA, Oct. 9, 2022 /PRNewswire/ -- Eating a Mediterranean diet, rich in fibre, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunotherapy response rates and progression-free survival in advanced melanoma patients, a new study presented today at UEG Week 2022 has found. Experts anticipate that the diet will play an important role in the success of immunotherapy...
Antengene Announces Upcoming Presentations at the 2022 Society for Immunotherapy of Cancer Annual Meeting
Oral presentation highlights preclinical data of ATG-031, an in-house discovered anti-CD24 monoclonal antibody Three poster presentations showcase preclinical data of ATG-101, a PD-L1/4-1BB bispecific antibody developed in-house, ATG-018, an ATR inhibitor discovered in-house, and ATG-027, a B7H3/PD-L1 bispecific antibody discovered in-house Antengene has global rights to these pipeline assets SHANGHAI and...
Everest Medicines Announces Approval of XERAVA® in Hong Kong for the Treatment of Complicated Intra-Abdominal Infections
SHANGHAI, Oct. 8, 2022 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest Medicines", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asia, announced today that the Department of Health of the Hong Kong Special Administrative Region, China, has approved a New Drug Application (NDA) for...
First patient treated in Clarity’s therapeutic prostate cancer trial
Highlights Clarity Pharmaceuticals recruits and treats its first patient in the therapeutic phase of its SAR-bisPSMA theranostic clinical trial SECuRE (NCT04868604) investigating Targeted Copper Theranostics (TCTs) in patients with metastatic castrate-resistant prostate cancer (mCRPC) Data from the initial dosimetry phase with 64Cu SAR-bisPSMA was assessed by the Safety Review Committee which...
Hugel resubmits BLA for its botulinum toxin, Botulax to the U.S. FDA
Hugel received CRL from the U.S. FDA last March and completely supplemented documents and data. It is expected to obtain the U.S. FDA's approval in the first half of 2023 and aims to become a TOP 3 botulinum toxin brand in the U.S. market. SEOUL, South Korea, Oct. 7, 2022...
Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions
Raffles is the first hospital in Singapore to provide pre-emptive pharmacogenomics testing protocol Aims to reduce side effects due to inappropriate medications SINGAPORE, Oct. 7, 2022 /PRNewswire/ -- Raffles Medical Group (RMG) is collaborating with biotech start-up NalaGenetics to offer pre-emptive pharmacogenomics testing at its hospital. It is the first hospital in Singapore to provide such a service....
Medit wins four consecutive patent lawsuits against 3Shape
SEOUL, South Korea, Oct. 7, 2022 /PRNewswire/ -- Medit Corp. ("Medit"), a global provider of 3D scanning solutions, has successfully defended against four separate patent infringement actions filed in Germany by a Danish competitor, 3Shape A/S ("3Shape"). Over the past 3 years, 3Shape has aggressively pursued patent infringement actions against Medit based...
Synapse Medicine Initiates Multi-Site Implementation Study with Leading U.S Hospitals
Synapse Medicine clinical decision support technology analyzes drug-related risks based on each patient's clinical characteristics and will be studied for its impact on inpatient pharmacist efficacy and efficiency. The Synapse Medicine medication reconciliation tool will be deployed through an integration with the hospitals' current EPIC EHR workflow. The study also has...
EVERISE NAMED TO NEWSWEEK’S LIST OF THE TOP 100 MOST LOVED WORKPLACES FOR 2022
Everise is Among the Top 100 U.S. Companies Recognized for Employee Sentiment and Satisfaction for the Second Year in a Row NEW YORK, Oct. 7, 2022 /PRNewswire/ -- Newsweek announced today their annual rankings for the Top 100 Most Loved Workplaces® list. Everise made the list once again and was ranked #90. The 2022...
United Imaging Installs Broward County’s First uMI 550 at Holy Cross Health in Fort Lauderdale
Holy Cross procured the uMI 550 to "go digital" and continue to innovate for its community. HOUSTON, Oct. 7, 2022 /PRNewswire/ -- United Imaging, a global manufacturer of medical imaging equipment, announced the installation of Broward County's first uMI 550 at Holy Cross Health, a member of Trinity Health, in Fort Lauderdale, Florida. United Imaging innovates and produces equipment...
